Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neural correlates of episodic future thinking impairment in multiple sclerosis patients.
"Nine" syndrome: A new neuro-ophthalmologic syndrome: Report of two cases.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
PAMP-DAMPs interactions mediates development and progression of multiple sclerosis.
Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population.
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
Myeloproliferative neoplasms in five multiple sclerosis patients.
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: The impact of thalamic subnuclei on disability.
Defective Autoimmune Regulator-Dependent Central Tolerance to Myelin Protein Zero Is Linked to Autoimmune Peripheral Neuropathy.
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
Dentatorubrothalamic tract localization with postmortem MR diffusion tractography compared to histological 3D reconstruction.
[Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
Thy28 protects against anti-CD3-mediated thymic cell death in vivo.
Increased Affinity of JC Polyomavirus Capsid for LSTc Over Other Sialylated Glycans Is a Major Determinant of Infectivity.
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.
Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations.
Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.
Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »